Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
iCE Neurosystems is a private neurotechnology and medical device company developing an integrated neuromonitoring platform for critically ill patients. Its core offering combines single-use subcutaneous EEG electrodes, bedside and cloud software, and clinical decision-support tools to enable continuous brain monitoring without relying on traditional EEG technical workflows. The company’s products are designed to help hospitals detect, monitor, and prevent brain injury and related neurologic deterioration in ICU and other acute-care settings. Publicly available sources indicate the company has received FDA 510(k) clearances for its subcutaneous electrode systems and is focused on hospital deployment of its iCEWav platform and associated data services. Overall, iCE Neurosystems is best characterized as a neurocritical-care medtech company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iCE Neurosystems.